Ricerca

Pubblicazioni IRIS

• Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
  Anno: 2025
• JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib
  Anno: 2025
• Influence of medical educational background on the diagnostic quality of ChatGPT-4 responses in internal medicine: A pilot study
  Anno: 2025
• High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines
  Anno: 2022